237 related articles for article (PubMed ID: 16628961)
1. [Drug safety of NSAIDs and COX-2 inhibitors].
Herdegen T; Fauler J
Med Monatsschr Pharm; 2006 Apr; 29(4):122-8. PubMed ID: 16628961
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Hermann M; Ruschitzka F
Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
[TBL] [Abstract][Full Text] [Related]
3. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
Nurmohamed MT
Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165
[No Abstract] [Full Text] [Related]
4. Cardiovascular risks of cyclooxygenase inhibition.
Stacy ZA; Dobesh PP; Trujillo TC
Pharmacotherapy; 2006 Jul; 26(7):919-38. PubMed ID: 16803424
[TBL] [Abstract][Full Text] [Related]
5. [COX-2 Inhibitors for the management of postoperative pain].
Schug SA
Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jan; 45(1):56-63. PubMed ID: 20091477
[TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
Lange H; Eberhart L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O; Solomon SD
Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
[TBL] [Abstract][Full Text] [Related]
8. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
Scheiman JM
Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
[TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
van den Bemt BJ; Benraad HB; Rasker JJ
Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414
[TBL] [Abstract][Full Text] [Related]
10. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
Hinz B; Renner B; Brune K
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
[TBL] [Abstract][Full Text] [Related]
11. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
Hur C; Chan AT; Tramontano AC; Gazelle GS
Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Farkouh ME; Greenberg BP
Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Solomon SD
Curr Opin Cardiol; 2006 Nov; 21(6):613-7. PubMed ID: 17053413
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
15. What price pain relief?
Hochman JS; Shah NR
Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
[No Abstract] [Full Text] [Related]
16. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
17. The murky waters of the coxibs: a review of the current state of play.
Ostor AJ; Hazleman BL
Inflammopharmacology; 2005; 13(4):371-80. PubMed ID: 16354390
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
Joshi GP; Gertler R; Fricker R
Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
[TBL] [Abstract][Full Text] [Related]
19. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing?
Boursinos LA; Karachalios T; Poultsides L; Malizos KN
J Musculoskelet Neuronal Interact; 2009; 9(1):44-52. PubMed ID: 19240368
[TBL] [Abstract][Full Text] [Related]
20. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]